Early Phase Clinical Trials
Helping our clients navigate their Phase I-IB studies
PPD’s early development services keeps an eye toward supporting your later-phase programs.
PPD’s Early Development and Clinical Pharmacology Solutions
Our streamlined services help establish proof-of-concept by reducing time and cost from your development timeline.
Learn more about our Phase I capabilities
EARLY DEVELOPMENT GLOBAL CAPABILITIES
With over 100 studies awarded through our global network in the past five years, our areas of expertise include: renal impairment, hepatic impairment, Japanese Bridging, Chinese Bridging in China and NHV studies.
Early Development Services for Neurodegenerative Diseases
PPD’s early development services create an integrated approach for your neurodegenerative disease studies, including access to the right sites and the right patients. We have an established neuroscience team that will focus on your study startup. Our team will work closely with you to help deliver your life-changing therapy to patients as quickly as possible.